Bio-Link (Shanghai) Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 500

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 14

Bio-Link (Shanghai) General Information

Description

Developer and manufacturer of process solutions designed for life science companies. The company develops and manufactures key process equipment and consumables for vaccines, antibody drugs, cell therapy, gene therapy and other biologics including upstream cell culture, disposable dispensing reservoirs and downstream chromatography, ultrafiltration, filtration and other process units and process development services, enabling customers with high-quality innovative products and solutions with an efficient, safe and competitive biopharmaceutical supply chain ecosystem.

Contact Information

Website
www.biolink.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 15, No. 58, Shengxia Road
  • Pudong New District
  • Shanghai, 201200
  • China
+86 400
Primary Industry
Medical Supplies
Corporate Office
  • Building 15, No. 58, Shengxia Road
  • Pudong New District
  • Shanghai, 201200
  • China
+86 400

Bio-Link (Shanghai) Timeline

2022202320242025
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bio-Link (Shanghai) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 04-Nov-2024 Completed Generating Revenue
3. Early Stage VC (Series A1) 01-Nov-2023 Completed Generating Revenue
2. Early Stage VC 20-Feb-2023 Completed Generating Revenue
1. Early Stage VC (Series A) 30-Dec-2022 Completed Generating Revenue
To view Bio-Link (Shanghai)’s complete valuation and funding history, request access »

Bio-Link (Shanghai) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bio-Link (Shanghai) Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alwin Capital Venture Capital Minority
Shenzhen Capital Group Venture Capital Minority
Zoo Capital Venture Capital Minority
Haiwang Capital Venture Capital Minority
Trinity Innovation Fund Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Bio-Link (Shanghai) FAQs

  • When was Bio-Link (Shanghai) founded?

    Bio-Link (Shanghai) was founded in 2021.

  • Where is Bio-Link (Shanghai) headquartered?

    Bio-Link (Shanghai) is headquartered in Shanghai, China.

  • What is the size of Bio-Link (Shanghai)?

    Bio-Link (Shanghai) has 500 total employees.

  • What industry is Bio-Link (Shanghai) in?

    Bio-Link (Shanghai)’s primary industry is Medical Supplies.

  • Is Bio-Link (Shanghai) a private or public company?

    Bio-Link (Shanghai) is a Private company.

  • What is Bio-Link (Shanghai)’s current revenue?

    The current revenue for Bio-Link (Shanghai) is .

  • How much funding has Bio-Link (Shanghai) raised over time?

    Bio-Link (Shanghai) has raised $13M.

  • Who are Bio-Link (Shanghai)’s investors?

    Alwin Capital, Shenzhen Capital Group, Zoo Capital, Haiwang Capital, and Trinity Innovation Fund are 5 of 14 investors who have invested in Bio-Link (Shanghai).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »